Please contact me, if you are interested in any item.
Email: anthony@chembj.com
Skype: steroid.anthony
www.steroidslab.com
Description:
EVISTA (raloxifene) is supplied in a tablet dosage form for oral administration. Each EVISTA tablet contains 60 mg of raloxifene HCl, which is the molar equivalent of 55.71 mg of free base. Inactive ingredients include anhydrous lactose, carnauba wax, crospovidone, FD&C Blue No. 2 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, modified pharmaceutical glaze, polyethylene glycol, polysorbate 80, povidone, propylene glycol, and titanium dioxide.
Quick Detail:
product name | Raloxifene hydrochloride |
Alias | Raloxifene HCL |
CAS | 82640-04-8 |
Purity | 99% |
MF | C28H28ClNO4S |
MW | 510.04 |
Appearance | light yellow powder |
Usage | It is used in the prevention of osteoporosis in postmenopausal women |
Applications:
Raloxifene is used to prevent and treat bone loss (osteoporosis) in women after menopause. Maintaining strong bones by slowing bone loss helps to reduce the risk of fractures.
Raloxifene may also lower the chance of getting a certain type of breast cancer (invasive) in women after menopause.
This drug is different from hormones (including estrogens and progestins). It works by acting like estrogen (as a selective estrogen receptor modulator or SERM) in some parts of the body. Raloxifene helps to preserve bone mass, but it does not affect the breast and uterus like estrogen or relieve symptoms of menopause such as hot flashes.
This medication is not recommended for use in women before menopause. It should not be used in children...
Side effect: Raloxifene may infrequently cause serious blood clots to form in the legs, lungs, or eyes.